These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 25509271)
1. [Buzhong yiqi decoction containing serum reversed resistance of A549/DDP to cisplatin and its effect on the expression of survivin: an experimental research ]. Yi JL; Wang Y; Jing H; Shi YT; Liu CY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1250-5. PubMed ID: 25509271 [TBL] [Abstract][Full Text] [Related]
2. [Effects of Buzhong Yiqi decoction on expression of Bad, NF-κB, caspase-9, Survivin, and mTOR in nude mice with A549/DDP transplantation tumors]. Liu YL; Yi JL; Liu CY Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):725-730. PubMed ID: 28959844 [TBL] [Abstract][Full Text] [Related]
3. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell]. Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910 [No Abstract] [Full Text] [Related]
4. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells. Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line. Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998 [TBL] [Abstract][Full Text] [Related]
6. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells]. Zhang MC; Hu CP; Chen Q Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483 [TBL] [Abstract][Full Text] [Related]
7. [Effect of Buzhong Yiqi decoction on PI3K and AKT in spleen, stomach and lung of nude mice with lung adenocarcinoma transplantation tumor]. Liu YL; Wang Y; Yi JL; Jing H; Liu CY Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1869-73. PubMed ID: 25282897 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211 [TBL] [Abstract][Full Text] [Related]
9. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile]. Hu S; Hu CP; Liang CH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030 [TBL] [Abstract][Full Text] [Related]
10. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549. Liang H; Wang HB; Liu HZ; Wen XJ; Zhou QL; Yang CX Biomed Pharmacother; 2013 Jul; 67(6):503-9. PubMed ID: 23639227 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro. Chen XQ; Wang YL; Li ZY; Lin TY Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469 [TBL] [Abstract][Full Text] [Related]
12. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain]. Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356 [TBL] [Abstract][Full Text] [Related]
13. [Reversal effect of aloe emodin liposomes on cisplatin resistance line A549/DDP human lung adenocarcinoma cells]. Zeng R; Zhou ZW; Wu CF; Zhou YL Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1443-5. PubMed ID: 18837352 [TBL] [Abstract][Full Text] [Related]
14. [Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]. Xu RH; Yuan ZY; Guan ZZ; Li S Ai Zheng; 2005 Aug; 24(8):975-9. PubMed ID: 16086876 [TBL] [Abstract][Full Text] [Related]
15. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells. Zhang L; Liu X; Tang Z; Li X; Wang G Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028 [TBL] [Abstract][Full Text] [Related]
16. The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell. Teng X; Wang SY; Shi YQ; Fan XF; Liu S; Xing Y; Guo YY; Dong M Anticancer Drugs; 2021 Oct; 32(9):939-949. PubMed ID: 34001704 [TBL] [Abstract][Full Text] [Related]
17. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice]. Dai M; Luo RC; Zheng DY; Lü CW; Ding XM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788 [TBL] [Abstract][Full Text] [Related]
18. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138 [TBL] [Abstract][Full Text] [Related]
19. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719 [TBL] [Abstract][Full Text] [Related]
20. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway. Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]